The Board of Directors of amanta healthcare has approved a revision in the remuneration of its Chairman & Managing Director, Shri Bhavesh Girishbhai Patel. The decision was taken during a board meeting held on May 19, 2026. The revised remuneration is set at 13,29,000 P.M., compared to the existing remuneration of 10,00,000 P.M.

Remuneration Details

The increase in remuneration is effective from April 1, 2026. The appointment period will extend from the date of the Board Meeting until further re-appointment. The revision requires the approval of shareholders by way of a Special Resolution at the ensuing Annual General Meeting.

Meeting Proceedings

The board meeting commenced at 12:15 PM and concluded at 03:10 PM on May 19, 2026. The company has submitted the disclosure to the stock exchanges under Regulation 30 of the SEBI (LODR) Regulations, 2015.

Amanta Healthcare Limited has informed the stock exchanges that the audio recording of its earnings conference call for the quarter ended March 31, 2026 (Q4 FY26) is now available for access. The company stated that the recording has been uploaded to its official website.

The disclosure, addressed to the Senior General Managers of the Listing Departments at BSE Limited and the National Stock Exchange of India Limited, references the company's earlier intimation dated May 16, 2026. The audio file provides details regarding the financial performance and operational updates discussed during the conference call.

Investors and interested stakeholders can listen to the recording by visiting the dedicated investor relations section on the company's website. The specific link provided for accessing the audio is https://www.amanta.co.in/investor-meet .

The communication was signed by Nikhita Dinodia, the Company Secretary and Compliance Officer of Amanta Healthcare Limited. The intimation was submitted to the exchanges to ensure regulatory compliance and transparency for shareholders.

Key Details